References
- Ciolino LA. Quantitation of synthetic cannabinoids in plant materials using high performance liquid chromatography with UV detection (validated method). J Forensic Sci. 2015;60:1171–1181.
- DrugFacts: high school and youth trends. National Institute on Drug Abuse website [cited 2016 Jul 20]. Available from: https://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends.
- Palamar JJ, Acosta P. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend. 2015;149:194–202.
- Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend. 2011;117:152–157.
- Centers for Disease Control and Prevention. Notes from the field: severe illness associated with synthetic cannabinoid use—Brunswick, Georgia, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:939.
- Centers for Disease Control and Prevention. Notes from the field: severe illness associated with reported use of synthetic marijuana — Colorado. MMWR Morb Mortal Wkly Rep. 2013;62:1016–1017.
- Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid-related illnesses and deaths. N Engl J Med. 2015;373:103–107.
- Tyndall JA, Gerona R, De Portu G, et al. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA. Clin Toxicol (Phila). 2015;53:950–956.
- Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:93–98.
- Louh IK, Freeman WD. A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure. Crit Care. 2014;18:553.
- Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12–41.
- Lapoint J, James LP, Moran CL, et al. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol. 2011;49:760–764.
- Law R, Schier J, Martin C, et al. Increase in reported adverse health effects related to synthetic cannabinoid use—United States. MMWR Morb Mortal Wkly Rep. 2015;64:618–619.
- Kasper AM, Ridpath AD, Arnold JK, et al. Severe illness associated with reported use of synthetic cannabinoids—Mississippi, April 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1121–1122.
- Synthetic Cannabinoids [cited 2018 May 26]. Available from: The American Association of Poison Control Centers website. http://www.aapcc.org/alerts/synthetic-cannabinoids.
- Banister SD, Longworth M, Kevin R, et al. Pharmacology of Valinate and tert-Leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem Neurosci. 2016;7:1241–1254.
- Schedules of controlled substances: Temporary placement of the synthetic cannabinoid MAB-CHMINACA into Schedule I. Federal register 81 (24). Drug Enforcement Administration website [cited 2016 Jul 20]. Available from: http://www.deadiversion.usdoj.gov/fed_regs/rules/2016/fr0205_2.htm.
- DHH Bans Another Synthetic Drug. Baton Rouge, LA WAFB 9 News website. October 29, 2014 [cited 2015 May 11]. Available from: http://www.wafb.com/story/27157019/dhh-bans-another-synthetic-drug.
- Schedule I of controlled substances, MS Code § 41-29-113 (2013).
- Hoyte CO, Jacob J, Monte AA, et al. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60:435–438.
- Wood KE. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr. 2013;163:213–216.
- Adamowicz P, Gieroń J. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA. Clin Toxicol. 2016;54:650–654.
- Katz KD, Leonetti AL, Bailey BC, et al. Case series of synthetic cannabinoid intoxication from one toxicology center. Westjem. 2016;17:290–294.
- Dresen S, Ferreiros N, Putz M, et al. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom. 2010;45:1186–1194.
- Hoffman RS. Poison centers and poison epidemiology. In Hoffman R, Howland M, Lewin N, Nelson L, Goldfrank L, eds. Goldfrank's Toxicologic Emergencies. 10th ed. New York: McGraw Hill Education, 2015:1729–1730.